HAP Trading’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $53.7K | Buy |
31,500
+10,000
| +47% | +$467K | ﹤0.01% | 594 |
|
|
2025
Q2 | $31.2K | Sell |
21,500
-2,300
| -10% | -$113K | ﹤0.01% | 562 |
|
|
2025
Q1 | $99.8K | Sell |
23,800
-19,300
| -45% | -$1.12M | 0.01% | 398 |
|
|
2024
Q4 | $193K | Sell |
43,100
-55,100
| -56% | -$3.08M | 0.02% | 318 |
|
|
2024
Q3 | $333K | Buy |
98,200
+71,000
| +261% | +$3.33M | 0.04% | 240 |
|
|
2024
Q2 | $22.1K | Buy |
27,200
+10,300
| +61% | +$461K | ﹤0.01% | 522 |
|
|
2024
Q1 | $26.4K | Sell |
16,900
-10,900
| -39% | -$555K | ﹤0.01% | 498 |
|
|
2023
Q4 | $17.8K | Buy |
27,800
+15,500
| +126% | +$814K | ﹤0.01% | 613 |
|
|
2023
Q3 | $4.82K | Buy |
+12,300
| New | +$754K | ﹤0.01% | 871 |
|
|
2023
Q2 | – | Sell |
-47,300
| Closed | -$19K | – | 1112 |
|
|
2023
Q1 | $19K | Buy |
47,300
+13,000
| +38% | +$917K | ﹤0.01% | 735 |
|
|
2022
Q4 | $54K | Buy |
34,300
+4,000
| +13% | +$302K | 0.01% | 719 |
|
|
2022
Q3 | $74K | Sell |
30,300
-2,000
| -6% | -$145K | ﹤0.01% | 871 |
|
|
2022
Q2 | $151K | Hold |
32,300
| – | – | 0.01% | 791 |
|
|
2022
Q1 | $132K | Sell |
32,300
-27,000
| -46% | -$1.81M | 0.01% | 956 |
|
|
2021
Q4 | $145K | Sell |
59,300
-31,100
| -34% | -$1.82M | ﹤0.01% | 1113 |
|
|
2021
Q3 | $99K | Buy |
90,400
+13,400
| +17% | +$882K | ﹤0.01% | 1255 |
|
|
2021
Q2 | $96K | Buy |
77,000
+36,400
| +90% | +$2.37M | ﹤0.01% | 1227 |
|
|
2021
Q1 | $103K | Sell |
40,600
-10,500
| -21% | -$653K | 0.01% | 949 |
|
|
2020
Q4 | $66K | Sell |
51,100
-3,200
| -6% | -$197K | ﹤0.01% | 1314 |
|
|
2020
Q3 | $114K | Buy |
54,300
+11,500
| +27% | +$692K | 0.01% | 772 |
|
|
2020
Q2 | $161K | Sell |
42,800
-12,400
| -22% | -$742K | 0.01% | 742 |
|
|
2020
Q1 | $235K | Buy |
+55,200
| New | +$3.37M | 0.02% | 508 |
|
|
2019
Q4 | – | Sell |
-1,299,400
| Closed | -$2.25M | – | 1246 |
|
|
2019
Q3 | $2.25M | Buy |
1,299,400
+194,200
| +18% | +$9.13M | 0.18% | 106 |
|
|
2019
Q2 | $894K | Sell |
1,105,200
-2,558,200
| -70% | -$119M | 0.07% | 235 |
|
|
2019
Q1 | $505K | Buy |
3,663,400
+3,554,400
| +3,261% | +$177M | 0.05% | 279 |
|
|
2018
Q4 | $20K | Buy |
+109,000
| New | +$5.86M | ﹤0.01% | 870 |
|
|
2018
Q2 | – | Sell |
-131,000
| Closed | -$155K | – | 988 |
|
|
2018
Q1 | $155K | Sell |
131,000
-456,200
| -78% | -$29.3M | 0.01% | 489 |
|
|
2017
Q4 | $889K | Sell |
587,200
-4,000
| -0.7% | -$250K | 0.04% | 296 |
|
|
2017
Q3 | $2.64M | Sell |
591,200
-11,300
| -2% | -$660K | 0.13% | 142 |
|
|
2017
Q2 | $1.37M | Sell |
602,500
-50,600
| -8% | -$2.75M | 0.07% | 222 |
|
|
2017
Q1 | $1.16M | Buy |
653,100
+388,400
| +147% | +$21.3M | 0.07% | 215 |
|
|
2016
Q4 | $395K | Buy |
264,700
+220,900
| +504% | +$12.1M | 0.02% | 380 |
|
|
2016
Q3 | $7K | Buy |
43,800
+16,100
| +58% | +$1.03M | ﹤0.01% | 1011 |
|
|
2016
Q2 | $57K | Buy |
27,700
+11,500
| +71% | +$813K | ﹤0.01% | 589 |
|
|
2016
Q1 | $19K | Sell |
16,200
-35,200
| -68% | -$2.22M | ﹤0.01% | 624 |
|
|
2015
Q4 | $113K | Sell |
51,400
-484,000
| -90% | -$32M | 0.01% | 543 |
|
|
2015
Q3 | $109K | Buy |
535,400
+485,100
| +964% | +$30.8M | 0.01% | 597 |
|
|
2015
Q2 | $147K | Sell |
50,300
-1,000
| -2% | -$65.9K | 0.01% | 520 |
|
|
2015
Q1 | $137K | Sell |
51,300
-442,800
| -90% | -$27.7M | 0.01% | 488 |
|
|
2014
Q4 | $413K | Buy |
+494,100
| New | +$27.9M | 0.02% | 476 |
|
|
2014
Q2 | – | Sell |
-202,100
| Closed | -$290K | – | 948 |
|
|
2014
Q1 | $290K | Buy |
+202,100
| New | +$10.8M | 0.01% | 551 |
|
Other funds holding BMY
HAP Trading's BMY Position: Q3 2024 in Review
HAP Trading sold out of Bristol-Myers Squibb (BMY) in Q3 2024, closing a stake of 32,509 shares — an estimated $1.53M sold.
HAP Trading first reported a position in BMY in Q2 2013 and held it in 22 quarters. The position peaked at $288M in Q4 2019. 2,259 funds tracked by Wall St. Rank hold BMY as of Q3 2024.
- HAP Trading reported no remaining Bristol-Myers Squibb position as of Q3 2024 after selling out during the quarter.
- HAP Trading sold 32,509 Bristol-Myers Squibb shares in Q3 2024, an estimated $1.53M.
- HAP Trading first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 22 quarters.
- HAP Trading's Bristol-Myers Squibb position peaked at $288M in Q4 2019.
- 2,259 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2024.
Based on HAP Trading's 13F filing for Q3 2024, filed 12 Nov 2024.